Phase II safety and clinical comparison with single-photon emission computed tomography myocardial perfusion imaging for detection of coronary artery disease: flurpiridaz F 18 … DS Berman, J Maddahi, BK Tamarappoo, J Czernin, R Taillefer, ... Journal of the American College of Cardiology 61 (4), 469-477, 2013 | 197 | 2013 |
Design, Synthesis, and Evaluation of Radiolabeled Integrin αvβ3 Receptor Antagonists for Tumor Imaging and Radiotherapy TD Harris, S Kalogeropoulos, T Nguyen, S Liu, J Bartis, C Ellars, ... Cancer Biotherapy and radiopharmaceuticals 18 (4), 627-641, 2003 | 134 | 2003 |
Phase I, first-in-human study of BMS747158, a novel 18F-labeled tracer for myocardial perfusion PET: dosimetry, biodistribution, safety, and imaging characteristics after a … J Maddahi, J Czernin, J Lazewatsky, SC Huang, M Dahlbom, H Schelbert, ... Journal of Nuclear Medicine 52 (9), 1490-1498, 2011 | 132 | 2011 |
Evaluation of LMI1195, a Novel 18F-Labeled Cardiac Neuronal PET Imaging Agent, in Cells and Animal Models M Yu, J Bozek, M Lamoy, M Guaraldi, P Silva, M Kagan, P Yalamanchili, ... Circulation: Cardiovascular Imaging 4 (4), 435-443, 2011 | 106 | 2011 |
Biodistribution and radiation dosimetry of LMI1195: first-in-human study of a novel 18F-labeled tracer for imaging myocardial innervation AJ Sinusas, J Lazewatsky, J Brunetti, G Heller, A Srivastava, YH Liu, ... Journal of Nuclear Medicine 55 (9), 1445-1451, 2014 | 99 | 2014 |
MRI of coronary wall remodeling in a swine model of coronary injury using an elastin-binding contrast agent C von Bary, M Makowski, A Preissel, A Keithahn, A Warley, E Spuentrup, ... Circulation: Cardiovascular Imaging 4 (2), 147-155, 2011 | 82 | 2011 |
Biological evaluation of thrombus imaging agents utilizing water soluble phosphines and tricine as coligands when used to label a hydrazinonicotinamide-modified cyclic … JA Barrett, AC Crocker, DJ Damphousse, SJ Heminway, S Liu, ... Bioconjugate chemistry 8 (2), 155-160, 1997 | 76 | 1997 |
Early scintigraphic detection of experimental myocardial infarction in dogs with technetium-99m-glucaric acid. C Orlandi, PD Crane, DS Edwards, SH Platts, L Bernard, J Lazewatsky, ... Journal of nuclear medicine: official publication, Society of Nuclear …, 1991 | 76 | 1991 |
Phase-III clinical trial of fluorine-18 flurpiridaz positron emission tomography for evaluation of coronary artery disease J Maddahi, J Lazewatsky, JE Udelson, DS Berman, RSB Beanlands, ... Journal of the American College of Cardiology 76 (4), 391-401, 2020 | 75 | 2020 |
Dual-gated motion-frozen cardiac PET with flurpiridaz F 18 PJ Slomka, M Rubeaux, L Le Meunier, D Dey, JL Lazewatsky, T Pan, ... Journal of Nuclear Medicine 56 (12), 1876-1881, 2015 | 54 | 2015 |
Automatic 3D registration of dynamic stress and rest 82Rb and flurpiridaz F 18 myocardial perfusion PET data for patient motion detection and correction J Woo, B Tamarappoo, D Dey, R Nakazato, L Le Meunier, A Ramesh, ... Medical physics 38 (11), 6313-6326, 2011 | 47 | 2011 |
Structure−Activity Relationships of 111In- and 99mTc-Labeled Quinolin-4-one Peptidomimetics as Ligands for the Vitronectin Receptor: Potential Tumor Imaging … TD Harris, S Kalogeropoulos, T Nguyen, G Dwyer, DS Edwards, S Liu, ... Bioconjugate chemistry 17 (5), 1294-1313, 2006 | 46 | 2006 |
Technetium-99m (Sn2+) pyrophosphate in ischemic and infarcted dog myocardium in early stages of acute coronary occlusion: histochemical and tissue-counting comparisons JA Bianco, AJ Kemper, A Taylor, J Lazewatsky, DE Tow, SF Khuri Journal of Nuclear Medicine 24 (6), 485-491, 1983 | 38 | 1983 |
Tc-99m-labeled fibrinogen receptor antagonists: design and synthesis of cyclic RGD peptides for the detection of thrombi TD Harris, M Rajopadhye, PR Damphousse, D Glowacka, K Yu, ... Bioorganic & Medicinal Chemistry Letters 6 (15), 1741-1746, 1996 | 30 | 1996 |
Methods and apparatus for synthesizing imaging agents, and intermediates thereof RR Cesati, EH Cheesman, J Lazewatsky, HS Radeke, E Mongeau, ... US Patent 8,936,777, 2015 | 26 | 2015 |
Dosimetry, biodistribution, and safety of flurpiridaz F 18 in healthy subjects undergoing rest and exercise or pharmacological stress PET myocardial perfusion imaging J Maddahi, F Bengel, J Czernin, P Crane, M Dahlbom, H Schelbert, ... Journal of Nuclear Cardiology 26 (6), 2018-2030, 2019 | 24 | 2019 |
BMS753951: a novel low molecular weight magnetic resonance contrast agent selective for arterial wall imaging D Onthank, P Yalamanchili, R Cesati, J Lazewatsky, M Azure, M Hayes, ... Circulation 116 (suppl_16), II_411-II_412, 2007 | 24 | 2007 |
Radiolabeled divalent peptidomimetic vitronectin receptor antagonists as potential tumor radiotherapeutic and imaging agents TD Harris, E Cheesman, AR Harris, R Sachleben, DS Edwards, S Liu, ... Bioconjugate chemistry 18 (4), 1266-1279, 2007 | 23 | 2007 |
Contrast agents for applications including perfusion imaging SP Robinson, DS Casebier, M Yu, M Kagan, J Lazewatsky US Patent 9,408,927, 2016 | 21 | 2016 |
Autoradiography and radioscintigraphy of technetium-99m-sestamibi in c-neu transgenic mice PD Crane, DC Onthank, CR Bourque, SJ Heminway, TJ Mazaika, I Leav, ... Journal of Nuclear Medicine 36 (10), 1862-1868, 1995 | 19 | 1995 |